Skin diseases and palpable masses are a common presentation in guinea pigs brought for veterinary care2.
However, few studies have thus far looked at the prevalence of spontaneously arising diseases in pet guinea pigs.
"Lumpy bumpy guinea pigs: a retrospective study of 619 biopsy samples of externally palpable masses submitted from pet guinea pigs for histopathology" retrospectively analysed 619 biopsy samples submitted for histopathology from pet guinea pigs that had presented with externally palpable masses.
The purpose was to determine the most common tissue origins of these masses and the most frequent pathological diagnoses, together with signalment data for the most commonly diagnosed lesions.
Of the 619 samples submitted from 493 animals, 54 (8.7%) had arisen from the mammary glands3 and 15 (2.4%) from the thyroid glands, with the remaining 550 (88.9%) involving the skin and subcutis, muscle (n = 1), salivary glands (n = 4), lips (n = 2), ears (n = 4) and peripheral lymph nodes (n = 23).
Forty-seven (7.6%) of the masses were diagnosed as inflammatory in nature, including dermatitis, panniculitis, lymphadenitis, cheilitis, myositis, sialoadenitis, abscess and chronic inflammation with osseous metaplasia.
Non-neoplastic, non-inflammatory lesions accounted for a further 31 (5.0%), namely cysts, hamartomas, hyperplastic lesions, polyps, ectopic bone formation and salivary gland steatosis.
The remainder of the samples were neoplastic in nature (541; 87.4%), with 99 masses classified as epithelial in origin, 347 as mesenchymal, 23 as round cell, five as melanocytic and eight as unclassified malignant neoplasms.
Of these, mesenchymal neoplasms were further subdivided into benign (288) and malignant (59).
Lipomas were the most common neoplasm diagnosed, accounting for 286 of all samples submitted.
Of all 619 samples included in the study, the eight most commonly diagnosed lesions were lipoma (46.2%), trichofolliculoma (12.3%), sarcoma (of various subtypes: 9.5%), inflammation (all sites 7.6%), lymphoma / leukaemia (3.4%), mammary carcinoma (4%), mammary adenoma (3.2%) and thyroid carcinoma (1.5%).
Overall these eight diagnoses accounted for 87.7% of all submissions from the externally palpable masses from the pet guinea pigs submitted for histopathology.
Melanie said: “Guinea pigs are an increasingly popular household pet.
"Skin diseases, including palpable masses, are a common reason for veterinary presentation. But few studies have been published to date that provide information for clinicians about these conditions.
“This study illustrates the importance of neoplasms of the skin and subcutis in pet guinea pigs, with over 87% of the cases analysed having one of eight diagnoses.
"While most of these neoplasms are benign, a substantial minority are malignant and identifying those lesions is especially important in treatment planning.
"Clinicians dealing with pet guinea pigs should also be aware that some externally palpable masses may arise from the thyroid or mammary glands rather than the skin or subcutis, and that male guinea pigs may also develop mammary lesions.”
The paper has been selected as ‘Editor’s Choice’ by the Journal of Comparative Pathology and will be free to access until September on Lumpy, bumpy guinea pigs: a retrospective study of 619 biopsy samples of externally palpable masses submitted from pet guinea pigs for histopathology - ScienceDirect.
References
Miss Herdman faced three charges.
The first was that she indicated to a friend that she would supply diazepam and/or tramadol for use by their husband.
The second was that she supplied diazepam and/or tramadol and/or gabapentin.
The third was that she gave advice on the dosages of diazepam and/or tramadol and/or gabapentin.
Miss Herdman was not present at the hearing and was unrepresented, but the Committee determined that it was appropriate to proceed in her absence as she had been notified, was aware that the hearing was taking place and her absence was voluntary.
However, Miss Herdman had been in contact to indicate her pleas to the charges.
She admitted the intention to supply diazepam and/or tramadol and that she had provided advice on the dosages.
She also admitted that she had supplied diazepam but strongly denied that she had supplied tramadol and/or gabapentin.
Taking all the evidence into account (including messages sent by Miss Herdman and her admissions), the Committee found proven the charges in relation to the intent to supply and the advice on dosages.
The Committee also found proven the charge in relation to the supply of diazepam, but found not proved the charge relating to the supply of tramadol and gabapentin for several reasons, including the fact that the messages sent by Miss Herdman did not point unequivocally to her actually suppling each of the drugs to which she referred.
There was no suggestion that the diazepam was stolen from her place of work.
The Committee found that Miss Herdman’s actions had breached paragraphs 1.5 and 6.5 of the Code of Professional Conduct for Veterinary Nurses.
The committee judged that there were a number of aggravating features of Miss Herdman’s conduct, including that she was not qualified or authorised to prescribe medication to animals, let alone to human beings and that providing a controlled drug to a person who was already taking various painkilling medications was reckless.
The Committee also felt that a reasonable and informed member of the public would be very concerned to learn that a veterinary nurse had supplied a controlled drug to a friend for their personal use.
Regarding the sanction for Miss Herdman, Paul Morris, chairing the Veterinary Nursing Disciplinary Committee and speaking on its behalf, said: “Drawing all the material together, and considering the matter as a whole, the Committee had to impose a proportionate sanction for an isolated incident of serious professional misconduct which arose out of a misguided attempt to help a friend.
"The conduct in question was entirely out of keeping with Miss Herdman’s usual practice and there is no real risk that it will be repeated.
"However, this case was much too serious to take no further action and no useful purpose would be served by postponing a sanction.
“The Committee considered that a warning or reprimand would not be sufficient to satisfy the public interest as veterinary nurses are trusted by the public to deal with medication responsibly and failure to do constitutes a severe breach of trust.
“The Committee therefore considered a period of suspension sufficient to meet the public interest in maintaining the reputation of the profession and declaring and upholding proper standards of conduct for members of the profession.
“The Committee also considered whether a removal order would be appropriate but concluded it would be disproportionate and that such a step would remove from the profession an experienced, competent and valuable veterinary nurse for no discernible benefit.
“It was decided that Miss Herdman’s registration be suspended for a period of three months – a period which is sufficient to mark the gravity of the misconduct while taking into account the circumstances in which it arose.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings/
The day will be led by Sonya Miles, BVSc CertAVP (ZM), CertAqV, MRCVS, RCVS Recognised Advanced Practitioner in Zoological Medicine and WAVMA Certified Aquatic Species Veterinarian.
Lectures will look at techniques, protocols, potential drug options and combinations as well as blood sampling and hospitalisation techniques in a wide variety of exotic species.
Delegates will also be provided with lecture notes, a CPD certificate, refreshments and lunch, as well as goodie bags provided by sponsors Pinmoore Animal Laboratory Services Limited.
Sonya says the aim of the day is to dispel many myths associated with anaesthetising a wide variety of exotic species, including fish and amphibians, whilst simultaneously providing vets and nurses with the skills to undertake these often challenging and comparatively high-risk anaesthetics.
To book your place or for more information, email: info@justexotics.co.uk or book online at https://justexoticsevents.co.uk/dont-miss-out-on-our-latest-event
Phovia, which was launched in the UK last year, is a two-part FLE system consisting of a chromophore gel that is applied to the affected skin and a blue light LED lamp.
Vetoquinol says that when used together they produce light of varying wavelengths that penetrates the skin to different depths, helping to control bacteria and reduce inflammation on the surface of the skin and stimulating regeneration in the epidermal and dermal layers.
The unit is portable, and applications take four minutes once a week.
The authors of the Vetoquinol-funded study say that FLE has already been shown to support and accelerate natural skin healing, but this latest research shows that the benefits go beyond improvement in clinical signs.
The study looked at 35 dogs with a diverse range of skin conditions: 13 had interdigital furunculosis, 10 had deep pyoderma, 6 had wounds, 4 had pyotraumatic dermatitis, and 2 had perianal fistula on presentation.
Eight of 35 dogs were new cases, whereas the remaining 27 were undergoing recrudescence of a prior episode, including pyotraumatic dermatitis, wounds, deep pyoderma, interdigital furunculosis and perianal fistulae.
Thirty dogs (86%) achieved a clinical resolution: 18 with the Fluorescent Light Energy alone and 12 with the concomitant use of FLE and topical antiseptic shampoo.
Five dogs (14%) had a partial response and needed other therapies.
92% percent of owners attested to their pet’s enhanced quality of life, with 74% of dogs displaying at least a 50% improvement in owner-reported behaviour, mood, sleep and playing activities.
The study also reported a 46% reduction in caregiver burden.
Felicity Caddick, Technical Services Manager at Vetoquinol said: “Managing skin conditions often requires the long-term use of shampoos or topical therapies.
"Many owners find this aspect of pet ownership challenging, especially with larger dogs, or less cooperative animals.
"FLE can reduce or in some cases eliminate the need for topical therapies at home, not only simplifying the treatment process but also enhancing convenience and compliance.
"Sharing responsibility for administering ongoing treatment with their vet practice also removes some of the worry associated with their pet’s health.”
Vetoquinol also highlights that Phovia can offer vets a drug-free management option for skin disorders that aligns with the principles of antibiotic stewardship.
Reference
The webinar will allow veterinary teams to learn from three expert speakers how they can make small practical changes to have positive impacts in their own settings.
Helen Ballantyne, Chair of the UK One Health Coordination Group (UKOHCG) and both a human and animal health nurse, will provide a ‘human’ view of One Health and the strategies in the NHS.
She will highlight areas of excellent practice she has experienced, and from a One Health angle where the veterinary profession could learn from the NHS, and vice versa.
Fergus Allerton MRCVS, an Internal Medicine Specialist and lead on antimicrobial resistance (AMR) at Linnaeus will talk about, amongst other things, the optimal use of antimicrobials for infection control.
In collaboration with the NHS, he launched Veterinary Antibiotic Amnesty activity which saw a 19% reduction of antimicrobial use across the Linnaeus veterinary group.
Fergus will also talk about the PROTECT ME guidelines on the responsible use of antibacterials, such as for surgical antibiotic prophylaxis.
Simon Doherty, past-president of the British Veterinary Association and one of two BVA representatives at the Federation of Veterinarians in Europe, will focus on the history of One Health and One Agriculture; highlighting how improved communication and collaboration at the intersection of people, animals and the environment can drive productivity and sustainability in food production.
Simon will also share some of Vet Sustain’s farm animal resources and how the principles can be applied.
To register, visit: https://horiba.link/one-health-webinar
The 'Lifelong Ear Partnership' resources, which were developed in conjunction with a panel of vets, are designed to help practice teams improve their owner communication and achieve owner buy-in about otitis.
To that end, Dechra has developed various owner communication tools for use in practice or to refer owners to after the consultation.
They include an owner website: www.ear-inflammation.co.uk and a postcard with QR code links to educational videos which cover clinical recommendations, treatment options and the importance of revisits.
There is also a brochure for owners and an online 4D ear model: www.4d-earmodel.com, which demonstrates a healthy ear and an ear with mild, moderate or severe otitis.
Finally, Dechra has also launched an ear cytology webinar series on Dechra Academy: www.dechra.co.uk/academy.
The course consists of tips for everything from greeting the patient to performing and interpreting cytology slides.
www.dechra.co.uk/otitis-externa.
New statistics from the Voice of the Veterinary Profession Spring 2022 survey showed that while veterinary work is often seen as a vocation, 77% of vets list pay among their top five priorities when choosing a job.
Other deciding factors include geographical location (74%), area of practice (62%), low staff turnover (45%) and structured career progression (28%).
However only 42% of vets who responded to the survey considered their pay and benefits to be either ‘good’, ‘very good’, or ‘excellent’.
BVA President Malcolm Morley, said: “Fair, transparent and equal pay is one of the keystones of good veterinary workplaces.
"Whether you’re an employee, a manager or an employer, it’s vital that everyone feels confident that their workplace approaches pay in a clear and consistent way.
"This isn’t about paying everyone more; it’s about using objective criteria and transparent pay scales to ensure the whole team understands how decisions about reward and recognition are made and what they can do to access higher pay.”
The new resource, created for BVA members as part of its Good Veterinary Workplaces campaign, includes information for veterinary employers on the benefits a clear pay structure can bring for the whole team.
It demonstrates the positive impact transparency around reward and recognition can have on employee fulfilment and retention, and outlines the legal requirements of employers to ensure that pay is equitable.
It also offers tips for employees and managers for approaching conversations about pay and emphasises the importance of considering ‘total reward’ during these conversations.
Total reward is the entire sum of a job’s offering including, but not limited to, salary, commission structure, benefits package, CPD, work/life balance, promotion opportunities, travel expenses, accommodation, and so on.
Malcolm added: “We know that pay can be a fraught, and even somewhat taboo, subject but it is one that we all have a responsibility to tackle if we want to ensure that veterinary professionals are fairly rewarded for their work.
"We hope that this new guide will support all our members and equip them with the knowledge required to ensure they can confidently navigate conversations about pay.”
https://www.bva.co.uk/talking-pay
The Linnaeus OAPC initiative was launched in 2021 and originally allocated £30K for 2022.
However, that figure was doubled after the company received a growing number of high quality submissions.
33 papers were accepted for funding in 2022, of which 24 have so far been published and the remainder are undergoing peer review.
The authors comprise clinicians, specialists, residents and interns across nine referral and primary care sites within the group.
The OAPC was introduced by Professor Luisa De Risio, Clinical Research & Excellence Director at Linnaeus (pictured right).
She said: “By making clinical research open access, we can ensure it makes the widest possible impact – while also supporting the author’s profile and career development.
"We are continuing to offer OAPC funding to our associates in 2023 and look forward to seeing the fantastic research published as a result.”
To ask Shelly a question, first read her article here: https://www.veterinary-practice.com/article/pain-management-for-veterinary-nurses
Then join the VetNurse Clinical Article Club here: https://www.vetnurse.co.uk/001/vetnurse-clinical-article-club
Then post your question or discuss the article in this thread: https://www.vetnurse.co.uk/001/vetnurse-clinical-article-club/f/clinical-article-club-discussions/32396/pain-management-for-veterinary-nurses
£50 for the post which provokes the most discussion by the end of the week!
Remember, all time spent reading or participating in Clinical Article Club discussions can be claimed towards your annual CPD requirement: Press 'Claim CPD' at the top of the discussion thread.
32% said they find dog care to be too restrictive
29% said it would be too difficult to go on holiday
24% said they don’t want to walk the dog every day and 25% that having a dog is too expensive.
41% of those who said they regret getting a dog bought it during lockdown.
Zoetis has announced a supply problem with Equip Artervac, its vaccine against equine viral arteritis
The current inventory of Equip Artervac has an expiry date of March 29, 2023 and the company is not expecting a new batch to be available until the end of September 2023.
Zoetis says it has been working with relevant organisations to implement a plan to mitigate the impact on breeders.
The Thoroughbred Breeders Association has published advice for a blood sampling scheme at: https://www.rossdales.com/news-events/tba-members-equine-vaccine-advice-regarding-disruption-to-supply-of-equip-artervac, but Zoetis highlights that the advice requires action two weeks after the most recent EVA vaccination.
For more information contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0345 300 8034
The Association says it has produced the leaflet after seeing an increasing number of dogs diagnosed with clinical or subclinical infection, along with reports of its zoonotic impact.
The document outlines the most important considerations concerning B. canis including transmission, diagnosis, management, public health implications and legislative requirements.
It takes into consideration information available from relevant Government Departments.
BSAVA says the document is by no means exhaustive but is intended to provide useful information and signpost to further resources.
www.bsavalibrary.com/brucella_canis
Photo: Walker16/Wikipedia. CC BY-SA 4.0.
Membra is a transparent, water-resistant, non-toxic, biodegradable bandage replacement consisting of a hydrogel polymer which can be applied to open wounds.
It is initially applied as a liquid and quickly gels into a thin, flexible layer over the site.
The initial liquid phase of Membra allows it to cover open and irregular spaces as well as suture lines and it dries in minutes to form a barrier that covers and protects the incision site or wound.
Being transparent, Membra allows the wound to be seen by the veterinary team and pet owners.
Membra lasts for up to 14 days and naturally biodegrades over time.
Animus says that Membra lowers the risk of infection or dehiscence.
The company also says that hydrogel polymer has been shown to replace the need for adhesive bandaging on suture lines following major TPLO surgery.
A study concluded that the polymer did not appear to raise the prevalence of incisional complications after TPLO surgery and lasts for 14 days, rather than 24-48 hours with traditional bandaging1.
Nick Butcher MRCVS, owner of Animus Surgical in the UK, said: “Regular bandaging of open wounds can be costly, time-consuming and stressful for owners and their pets, requiring frequent visits to the practice.
"The bandaging of some open wounds can be impossible because of the location of the lesion or the affected species (e.g. exotic or aquatic animals) and more aggressive or nervous patients may require sedation.
"Used bandages also add to the volume of clinical waste generated by the practice which requires incineration
“We are therefore delighted to launch Membra to veterinary teams in the UK.
"It has been very successful in the U.S. and we already have a number of UK vets using the product as Membra can positively affect the outcome of open wound management across a range of species, without the need for regular bandage changes.”
To find out how to apply Membra, a range of YouTube videos are available showing a selection of case examples: https://youtube.com/@sutureseal5917.
www.animussurgical.com.
The definition agreed by VN Council is as follows:
Veterinary nursing aims to ease the suffering and pain of animals, and to improve their health and welfare.
This includes providing any medical treatment or any minor surgery (not involving entry into a body cavity) to animals under the direction of a veterinary surgeon who has that animal under their care.
Veterinary nursing can be either proactive or reactive, and autonomous or collaborative. It is carried out in a wide variety of settings, for animals at all life stages, and considers the background and needs of the animal’s owner or keeper.
Matthew Rendle RVN, the Chair of VN Council, said: “Although it is just a few short lines, this definition of veterinary nursing has been in the pipeline for some time.
"While we as veterinary nurses have always been able to define ourselves by the type of tasks we carry out, or our relation to veterinary surgeons in terms of delegation, there hasn’t necessarily been a clear statement articulating the art and science of veterinary nursing.
“With the RCVS looking to expand its regulatory remit to include other veterinary paraprofessionals over the long term, we thought it was particularly important that we set out the stall for veterinary nursing and we hope that this clear statement will, in particular, aid the public in understanding the role of a veterinary nurse.
“It should be noted that this definition is VN Council’s own considered interpretation of the art and science of veterinary nursing.
"Other interpretations from other organisations, provided they conform with both Schedule 3 of the Veterinary Surgeons Act and the RCVS Code of Professional Conduct, could sit comfortably alongside ours, and we hope there continues to be healthy discussion about the contribution of the profession to the veterinary team, as our role evolves.”
What do you think of the definition and do you think it will help change the public and the profession's perceptions. Have your say here: https://www.vetnurse.co.uk/001/f/nonclinical-discussions/32399/what-do-you-think-of-the-new-rcvs-vn-council-definition-of-the-role-of-vet-nurses
The survey was conducted following the recent RCVS Council decision to redefine ‘Under Care’ to allow vets to prescribe remotely.
692 veterinary surgeons took part in the survey, 88.7% of which worked in practice, 8.7% worked elsewhere and 2.6% are retired.
42.4% worked in corporate practice, 42.4% at an independent practice (spooky), 9.6% locum and 2.6% at a charity.
94% worked in first opinion practice, 5.7% in referral practice.
When asked: “Do you agree with the RCVS Council decision to allow veterinary surgeons to prescribe medication without having seen / examined the animal in person?”, 78.2% said no, 13.6% said yes and 8.2% said ‘ambivalent’.
This raises an interesting discussion about the role of RCVS Council, which the College has long said is ‘representative of’, but not there 'to represent’ the profession in self-regulating.
By any measure, this decision was not ‘representative of’ the wider body of opinion.
It could be argued that electorates vote for representatives to make more informed decisions than they themselves are able, and certainly MPs have voted in ways that are not representative of the wider body of public opinion.
But this is the veterinary profession. MPs have to represent a wide cross-section of society, some groups of which might struggle to field one working brain cell between them.
By contrast, veterinary surgeons are a highly intelligent, highly educated subset of the population, who you might assume are better qualified to make decisions on matters such as these.
So why this level of disagreement? We asked respondents to select any benefits and drawbacks they think remote prescribing will bring, from a list but with the option for them to write in any we hadn’t thought of.
When asked to select benefits of remote prescribing, the majority (70.9%) selected: “Reduced cost to the pet owner (driving/parking etc)’.
39.3% said it would bring an improvement to vets’ quality of life through more flexible working.
27.5% said animal welfare would be improved through increased access to veterinary services.
14.3% said it would bring an ‘Improved client/vet relationship’.
Of those people who selected a benefit, 49.9% said the biggest benefit of remote prescribing is a reduced cost to the pet owner (driving / parking etc).
Other benefits highlighted in the comments section were
Notably, in the comments section for the benefits of remote prescribing, out of the 104 comments, 33 actually commented 'no benefit' or negatively.
When asked to select the drawbacks of remote prescribing, 94.3% selected: ‘Harm to animals caused by misdiagnoses and missed diagnoses.
68% said: Worsened client / vet relationship
60.6% said: Threat to independent practice (corporates funnelling clients from online consults to their practices).
Other drawbacks identified by respondents were:
Amongst the written drawbacks, the biggest themes concerned abuse of drugs and antimicrobial resistance.
When those who had selected a drawback were then asked which was the biggest, 83.3% said ‘Harm to animals caused by misdiagnoses and missed diagnoses”
So in simple terms, in weighing up the pros and cons, it’s between the reduced cost to the owner on the one hand, cited by 70.9%, and harm to animal welfare on the other, cited by 94%. And the harm to animal welfare was selected by significantly more vets as the biggest concern, than reduced cost was selected as the biggest benefit.
In other words, vets think remote prescribing will make veterinary care cheaper, but at the overall cost to animal welfare.
British Veterinary Association President Malcolm Morley said: “New technology presents many opportunities to enhance existing veterinary services, with potential benefits for vets, clients and patients.
"However, we recognise there are concerns within the profession, particularly around the potential unintended consequences of the RCVS’s revised guidance on ‘under care’ in relation to animal welfare and access to veterinary services.
"This survey echoes these concerns as well as supporting the British Veterinary Association’s call for the RCVS to commit to a post-implementation review.”
Omniflora paste is designed to provide fast acting support in acute digestive upset or strategically ahead of perceived stressful events such as travel or veterinary appointments.
It contains probiotics, prebiotics, adsorbents, parabiotics, postbiotics, electrolytes and nutrients.
Omniflora tablets are available for animals who resist an oral syringe.
The tablets contain probiotics, prebiotics and adsorbent clay and fibre.
Veterinary nurse and sales manager, Tara Evans, said: “Digestive upset in cats and dogs is common.
"We wanted to provide vets and pet owners with an easy-to-use solution that can be used in practice or at home.
"One tube of paste lasts for three consecutive days to support cats and dogs as they recover from gastrointestinal upset.”
"As well as supporting the gut in acute episodes of digestive upset such as diarrhoea, Omniflora can be used ahead of time in stressful events such as travelling, visiting the groomers, or any planned veterinary procedures such as surgeries or blood tests.”
Omniflora can be ordered here https://www.vitaanimalhealth.com/product/omniflora
The pair were invited to carry out the laparoscopic surgery on four dogs suffering from pulmonic stenosis by the British Veterinary Centre.
Chris said: “The British Veterinary Clinic had previously referred a case to Fabio at Willows and subsequently got in touch about a further four cases in need of surgery, inviting us to fly out to Abu Dhabi to operate on these cases for them.
“It was a pioneering moment for the British Veterinary Centre and a first for the region and the Middle East.
“It’s the very first time that interventional cardiology has been performed in the UAE so, with the fantastic facilities and dedicated staff at the BVC, we have made history in the region!
“It was also the first time that Fabio and I had worked together and now we hope that this will be the first of many such collaborations.”
Fabio added: “With our collective expertise and knowledge, we know we can improve the lives of so many dogs that are living with conditions like pulmonic stenosis.
“Two of the dogs required balloon valvuloplasty and two required pulmonary stents inserted.
“All four dogs had great initial post-operative results and would be expected to lead happier, healthier lives as a result of these procedures.'
The webinar will be presented by Dr Abigail McGlennon from the Equine Infectious Disease Surveillance (EIDS) team at the University of Cambridge who will present data from the Surveillance of Equine Strangles (SES) network to provide a detailed overview of strangles diagnoses across the UK.
Abigail will explore recent trends in outbreak reports, the genetic makeup of recent circulating strains and transmission links between UK outbreaks.
By linking research from her own PhD work on S. equi genomics and transmission with preventative strategies, Abigail show how to suggest and implement evidence-based prevention measures to clients.
The webinar will also offer advice on ‘the ates’ preventative measures – vaccinate, isolate, investigate and communicate – and will include information on when horse owners should be vaccinating with Strangvac and an outbreak management vaccination plan using the traffic light ‘green, amber and red’ system.
https://go.dechra.co.uk/preventative_strategies_for_strangles
Ki-67 is a proliferation marker used for assessing tumour aggressiveness, however the traditional method of assessing Ki-67 scores involves manually counting the proliferating cells, which is subjective, time-consuming and prone to variability.
Finn says its new AI-assisted Ki-67 scoring test represents a significant advancement in veterinary diagnostic oncopathology.
The AI algorithm analyses Ki-67 labelling across the entire section of tumour.
Positively labelled cells are highlighted, scores are calculated, and the results are validated by a pathologist before reporting.
This more automated analysis enables the evaluation of large volumes of histological data, ensuring consistent and reliable prognostic assessments.
Finn says it also removes the subjectivity and variability associated with identifying areas of highest cell proliferation, which is a crucial aspect of tumour scoring.
https://www.finnpathologists.com
The company has prepared practice marketing materials to support the campaign to educate pet owners on the signs of anxiety in cats and dogs, which are available from its Account Managers.
The campaign is being fronted by TV personality and radio presenter, Kate Lawler (pictured), who has taken on the role of official ambassador having experienced anxiety in her rescue Terrier cross, Shirley.
Ceva has partnered with Battersea Dogs and Cats Home for the campaign and will be making a donation of £1 for every Adaptil product sold during March.
http://www.petanxiety.co.uk
Successful candidates will get to work with a multidisciplinary team of specialists, including nurses with advanced qualifications, RCVS, European & American Diplomats, Veterinary Residents & Interns and Animal Care Assistants.
The Veterinary Nurse Rotating Internship is a one-year fixed term internship where interns will rotate through various departments, gaining experience and expanding their knowledge across a range of clinical disciplines such as theatre, emergency and critical care, wards nursing, anaesthesia, and more.
Applications for the August 2025 intake are now open: https://www.langfordvets.co.uk/work-with-us/nursing-rotating-internship-2025-2026/
The Veterinary Nurse Residency has been developed to support veterinary nurses who want to achieve their Veterinary Technician Specialism (VTS), in a specific discipline in which they would already hold extensive experience in.
The three year programme will allow successful applicants the opportunity to spend three years studying towards a Veterinary Technician Specialist qualification in Emergency and Critical Care, Anaesthesia and Analgesia, Internal Medicine or Neurology.
Applications for the 2025-2028 cohort are now open: https://www.langfordvets.co.uk/work-with-us/veterinary-nursing-residency-programme-2025-2028/
The panel will present the latest information on the prevalence of this zoonotic disease, review prevention strategies, and highlight the significance of cystic echinococcosis in humans.
The panelists are:
Dr Carolyn Kyte MRCVS (pictured), Elanco's UK Technical Consultant said: “We are concerned about potential changes in the distribution of Echinococcus granulosus in the UK and a subsequent change in zoonotic risk.
"We are hoping this cross-disciplinary discussion will provide Congress and Expo attendees with the latest insights the profession needs to allow individual, risk-based parasite control in dogs.
"The responsible use of parasiticides needs a true One-Health collaborative approach.”
Mrs Cole pleaded guilty to fraud in July 2024 at Crawley Magistrates’ Court and was sentenced to eight months in prison suspended for 12 months, 20 days rehabilitation activity and a £187 victim surcharge.
The College opened its own disciplinary investigation against Mrs Cole after receiving the certificate of conviction, which related to more than £13,000 of pet insurance fraud.
It then proceeded with the hearing in Mrs Cole’s absence as she had not responded to any of the communications sent to her by the College on the matter.
Having found the charge against her proven by the certificate of conviction, the Committee then determined that the conviction amounted to serious professional misconduct.
Dr Kathryn Peaty MRCVS, chairing the committee and speaking on its behalf, said: “The respondent’s conduct… was plainly dishonest and contravened a fundamental tenet of the profession.
"She abused her professional position in order to commit the offence.
"The dishonest conduct in this case related directly to the respondent’s professional life, as she was working as a veterinary nurse when she completed and submitted the fraudulent claims.
“Her conduct also constituted a breach of the trust owed to her employer and to the insurance company to which her dishonest claims were submitted.
"She put her professional colleagues at risk as their names were used on the clinical records which purportedly supported her dishonest claims.
“Her misconduct was repeated and sustained over a period of many years.
"Her modus operandi was sophisticated and premeditated.
“The respondent’s conduct clearly had the potential to bring the profession into disrepute and to undermine public trust in the profession.
"A member of the public would be rightly appalled to learn that a veterinary nurse had abused her position by submitting false claims in this way.”
The Committee found that there were no mitigating factors, and that aggravating factors included the premeditated nature of Mrs Cole’s fraud, the clear breaches of trust in respect of her colleagues, her clients and the insurance companies, the significant financial gain made from her fraud and the fact that the fraudulent activities were sustained and repeated over a period of four and a half years.
Kathryn added: “Taking into account the gravity of her misconduct, the need to maintain standards of probity in the profession, especially in relation to practice records and the submission of insurance claim documents, as well as the maintenance of public confidence in the profession, the Committee has resolved to direct the Registrar to remove the respondent’s name from the Register.
www.rcvs.org.uk/disciplinary
The pathway allows receptionists to progress through five stages of seniority, from receptionist to head receptionist - then beyond into practice and regional leadership roles.
It also shows how receptionists can branch out laterally into different roles within the group’s other divisions.
For each stage, there's a detailed outline of the necessary skills and capabilities and a curriculum of learning.
Philip Webb, Learning Partner at CVS who led the development of the pathway, said: “Receptionists are one of the most important roles in practice.
"They are the first and oftentimes key point of contact for our clients and play an instrumental role in how the workload of a practice is managed.
“We hope that the structured information and learning within our pathway will build the skills of each of our front-line colleagues, enhance the role of the receptionist in our practices, and give clear guidance on how to progress.
The sessions are:
https://www.bsavacongress.com/programme